Phenibut (β-Phenyl-γ-aminobutyric Acid) Dependence and Management of Withdrawal: Emerging Nootropics of Abuse
This case report describes the development of withdrawal from phenibut, a gamma-aminobutyric acid-receptor type B agonist. Although phenibut is not an FDA-approved medication, it is available through online retailers as a nootropic supplement. There are reports of dependence in patients that misuse...
Saved in:
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2018-01-01
|
| Series: | Case Reports in Psychiatry |
| Online Access: | http://dx.doi.org/10.1155/2018/9864285 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1832568415497224192 |
|---|---|
| author | Tania Ahuja Ofole Mgbako Caroline Katzman Allison Grossman |
| author_facet | Tania Ahuja Ofole Mgbako Caroline Katzman Allison Grossman |
| author_sort | Tania Ahuja |
| collection | DOAJ |
| description | This case report describes the development of withdrawal from phenibut, a gamma-aminobutyric acid-receptor type B agonist. Although phenibut is not an FDA-approved medication, it is available through online retailers as a nootropic supplement. There are reports of dependence in patients that misuse phenibut. We report a case in which a patient experienced withdrawal symptoms from phenibut and was successfully treated with a baclofen taper. This case report highlights the development of phenibut use disorder with coingestion of alcohol and potential management for phenibut withdrawal. We believe clinicians must be aware of how phenibut dependence may present and how to manage the withdrawal syndrome. |
| format | Article |
| id | doaj-art-1e9a230210df45e99a6dae6fd7f5d23f |
| institution | Kabale University |
| issn | 2090-682X 2090-6838 |
| language | English |
| publishDate | 2018-01-01 |
| publisher | Wiley |
| record_format | Article |
| series | Case Reports in Psychiatry |
| spelling | doaj-art-1e9a230210df45e99a6dae6fd7f5d23f2025-02-03T00:59:04ZengWileyCase Reports in Psychiatry2090-682X2090-68382018-01-01201810.1155/2018/98642859864285Phenibut (β-Phenyl-γ-aminobutyric Acid) Dependence and Management of Withdrawal: Emerging Nootropics of AbuseTania Ahuja0Ofole Mgbako1Caroline Katzman2Allison Grossman3Department of Pharmacy, New York University Langone Health, 550 First Avenue, New York, NY 10016, USADepartment of Medicine, New York University Langone Health, 550 First Avenue, New York, NY 10016, USANew York University School of Medicine, 550 First Avenue, New York, NY 10016, USADepartment of Psychiatry, New York University Langone Health, 550 First Avenue, New York, NY 10016, USAThis case report describes the development of withdrawal from phenibut, a gamma-aminobutyric acid-receptor type B agonist. Although phenibut is not an FDA-approved medication, it is available through online retailers as a nootropic supplement. There are reports of dependence in patients that misuse phenibut. We report a case in which a patient experienced withdrawal symptoms from phenibut and was successfully treated with a baclofen taper. This case report highlights the development of phenibut use disorder with coingestion of alcohol and potential management for phenibut withdrawal. We believe clinicians must be aware of how phenibut dependence may present and how to manage the withdrawal syndrome.http://dx.doi.org/10.1155/2018/9864285 |
| spellingShingle | Tania Ahuja Ofole Mgbako Caroline Katzman Allison Grossman Phenibut (β-Phenyl-γ-aminobutyric Acid) Dependence and Management of Withdrawal: Emerging Nootropics of Abuse Case Reports in Psychiatry |
| title | Phenibut (β-Phenyl-γ-aminobutyric Acid) Dependence and Management of Withdrawal: Emerging Nootropics of Abuse |
| title_full | Phenibut (β-Phenyl-γ-aminobutyric Acid) Dependence and Management of Withdrawal: Emerging Nootropics of Abuse |
| title_fullStr | Phenibut (β-Phenyl-γ-aminobutyric Acid) Dependence and Management of Withdrawal: Emerging Nootropics of Abuse |
| title_full_unstemmed | Phenibut (β-Phenyl-γ-aminobutyric Acid) Dependence and Management of Withdrawal: Emerging Nootropics of Abuse |
| title_short | Phenibut (β-Phenyl-γ-aminobutyric Acid) Dependence and Management of Withdrawal: Emerging Nootropics of Abuse |
| title_sort | phenibut β phenyl γ aminobutyric acid dependence and management of withdrawal emerging nootropics of abuse |
| url | http://dx.doi.org/10.1155/2018/9864285 |
| work_keys_str_mv | AT taniaahuja phenibutbphenylgaminobutyricaciddependenceandmanagementofwithdrawalemergingnootropicsofabuse AT ofolemgbako phenibutbphenylgaminobutyricaciddependenceandmanagementofwithdrawalemergingnootropicsofabuse AT carolinekatzman phenibutbphenylgaminobutyricaciddependenceandmanagementofwithdrawalemergingnootropicsofabuse AT allisongrossman phenibutbphenylgaminobutyricaciddependenceandmanagementofwithdrawalemergingnootropicsofabuse |